Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $6.81 Million - $7.83 Million
46,800 New
46,800 $7.58 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $7.44 Million - $8.01 Million
-48,200 Reduced 27.81%
125,100 $20.7 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $19.6 Million - $23.3 Million
129,500 Added 295.66%
173,300 $26.9 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $54.5 Million - $61.2 Million
-340,200 Reduced 88.59%
43,800 $7.74 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $62 Million - $68.9 Million
384,000 New
384,000 $62.7 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $14.8 Million - $16.4 Million
-88,100 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $13.9 Million - $15.8 Million
88,100 New
88,100 $15.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.